Medical/Pharmaceuticals

Meet Clicklinks: The Innovation Hub for Original Drug Discovery

SHANGHAI, May 23, 2026 /PRNewswire/ -- For many participants in the innovative drug discovery arena, AI-STAL and SAI-DA are already familiar names within the Sanyou Bio ecosystem. AI-STAL is recognized as the "Grand Master Librarian" safeguarding a Super Trillion Antibody Library, while SAI-DA is...

2026-05-23 22:00 4580

79th World Health Assembly adopts resolution on hemophilia and other bleeding disorders

MONTREAL, May 23, 2026 /PRNewswire/ -- On May 22, 2026, the 79th World Health Assembly unanimously adopted a resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders. This is a historic development for our community and will help increase diagno...

2026-05-23 02:00 4561

Texas Cardiac Arrhythmia Institute at St. David's Medical Center to host international conference on complex cardiac arrhythmias

EPLive 2026 is a two-day conference that draws the world's top cardiac electrophysiology experts AUSTIN, Texas, May 22, 2026 /PRNewswire/ -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center will host its eighth international symposium on complex arrhythmias on May 28-2...

2026-05-22 21:08 5643

Gene Solutions Showcases AI-Powered Multi-Omics Liquid Biopsy Innovations at TJCC 2026: Advancing Precision Oncology in Taiwan

Satellite symposium and exhibition engagement highlighted strong physician interest in MRD, MCED, and evidence-driven adoption of genomic testing. TAIPEI, May 22, 2026 /PRNewswire/ -- Gene Solutions , an innovative global biotechnology company advan...

2026-05-22 14:45 5716

Mabwell Announces Latest Clinical Data on 9MW2821 to Be Presented at 2026 ASCO Annual Meeting as Oral and Poster Presentations

SHANGHAI, May 21, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, will present multiple clinical study results of its novel Nectin-4-targeting ADC 9MW2821 (Bulumtatug Fuvedotin, BFv) at the 2026 American S...

2026-05-22 11:30 7161

Nuance Pharma Announces IND Clearance for Actair® Pivotal Clinical Trial in China

NMPA Approval Marks Key Milestone in Advancing House Dust Mite Allergy Immunotherapy to Chinese Patients SHANGHAI, May 22, 2026 /PRNewswire/ -- Nuance Pharma today announced that the National Medical Products Administration (NMPA) has cleared its Investigational New Drug (IND) application, enabl...

2026-05-22 09:50 4491

Kelun-Biotech to Present Two Registrational Studies in the Oral Presentation Session on Non-Small Cell Lung Cancer at ASCO 2026

* Sacituzumab tirumotecan (sac-TMT)(佳泰莱®) plus pembrolizumab versus pembrolizumab as first-line treatment for PD-L1 positive advanced NSCLC: Results from the randomized, controlled, registrational Phase III OptiTROP-Lung05 study (Abstract #8506) * Efficacy and safety of lunbotinib fumarate (A...

2026-05-22 08:00 6891

Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting

TAIPEI, May 21, 2026 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. announces that its abstract highlighting the differentiated binding profile and preclinical efficacy ofTSY-310, a novel bispecific antibody-drug conjugate (ADC), has been selected for presentation at the American Society of Clinic...

2026-05-22 05:34 4584

Kelun-Biotech Announces Phase III Trial of Sacituzumab Tirumotecan (sac-TMT) versus Chemotherapy as First‑line Treatment for Advanced TNBC Met Primary Endpoint of PFS

CHENGDU, China, May 21, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded that the Phase III clinical study (OptiTROP-Breast03) of the Company's tropho...

2026-05-21 22:08 7939

Guangzhou Lupeng/Newave Pharmaceutical Inc. Enrolled the First Patient in the Global Phase 3 ROCKET-CLL Trial Evaluating Rocbrutinib (LP-168) vs. Pirtobrutinib in R/R CLL/SLL

Head-to-Head Study Highlights Rocbrutinib as the World's First Fourth-Generation Dual Covalent and Non-Covalent BTK Inhibitor Designed to Overcome Resistance Mutations GUANGZHOU, China and SAN FRANCISCO, May 21, 2026 /PRNewswire/ -- Lupeng Pharmaceutical Ltd, a global clinical-stage biopharmaceu...

2026-05-21 22:00 6138

Neurophet Appoints Globally Renowned Imaging AI Expert Dr. Lawrence N. Tanenbaum as Scientific Advisor

* Former Vice President and Chief Technology Officer of RadNet, one of the largest outpatient imaging providers in the United States * Appointment expected to strengthen clinical validation, global expansion, and competitiveness in neuroimaging AI SEOUL, South Korea, May 21, 2026 /PRNewswire/...

2026-05-21 21:00 8143

Wincomm Secures Computex Best Choice Award for Three Consecutive Years (2024-2026), Leading the Future of AI-Powered Medical Solutions

HSINCHU, May 21, 2026 /PRNewswire/ -- Wincomm Corporation, a global leader in medical and industrial computing, is proud to announce it has achieved a prestigious milestone by winning the Computex Best Choice Award (BC Award) for three consecutive years from 2024 to 2026. This hat-trick of accola...

2026-05-21 15:16 4594

Singapore Court of Appeal Notes No Finding of Fraud Against KBP or Dr. Huang; Dispute with Novo Nordisk Undergoing Arbitration Proceedings

SINGAPORE, May 21, 2026 /PRNewswire/ -- KBP Biosciences Pte. Ltd. (the "Company " or "KBP") today issued a statement addressing the decision by the Singapore Court of Appeal to maintain the temporary injunction against the Company and its founder, Dr. Huang Zhenhua ("Dr. Huang"), pending final res...

2026-05-21 08:52 5802

Hyundai Bioscience Discloses XAFTY®'s IC50 Data for Ebola--"Secured Scientific Evidence for Immediate Treatment"

* Ebola IC50 (0.125μM)—Strong inhibition at less than half the concentration of the clinically-tested COVID-19 (0.28μM). * Clinical safety confirmed through COVID-19 and Dengue clinical trials. * Class-wide efficacy proven by accumulated research data for Hantavirus treatment. * Davey Smit...

2026-05-21 08:38 4663

Dimora Medical Launches Advanced Sacrum Silicone Absorbent Dressing to Enhance Pressure Injury Care

NEW YORK, May 20, 2026 /PRNewswire/ -- Dimora Medical, a continuous innovator in high-end medical care supplies, has introduced its new Sacrum Silicone Absorbent Soft Dressing, expanding its portfolio of home-based medical care solutions with a product designed to improve the management of pressu...

2026-05-21 01:50 4496

Sanyou Bio Launches SAI-DA 1.0, the AI-Drug Accelerator

SHANGHAI, May 20, 2026 /PRNewswire/ -- Sanyou Bio today announced the launch of SAI-DA 1.0 (Sanyou AI-Drug Accelerator). The platform builds on the company's AI-STAL (AI Super-Trillion Antibody Library), which serves as a vast molecular resource bank of super-trillion-scale molecules, SAI-DA 1.0 ...

2026-05-20 22:00 4888

DeepQure Announces Robust 3-Month Results from HERO-HTN Clinical Study at EuroPCR 2026

PARIS, May 20, 2026 /PRNewswire/ -- DeepQure, a clinical-stage medical device company, today announced robust 3-month clinical data from its HERO-HTN-FIH study during a featured presentation at EuroPCR 2026. The interim results demonstrate that the HyperQure™ extravascular renal denervation (RDN)...

2026-05-20 22:00 5548

United Imaging Highlights uMR Jupiter 5T and uMR Ultra, along with the latest MRI advancements at ISMRM 2026

CAPE TOWN, South Africa, May 20, 2026 /PRNewswire/ -- United Imaging, a global innovator in AI-powered advanced medical imaging technologies and intelligent healthcare solutions, showcased its comprehensive MRI portfolio, highlighting significant advancements across multiple fronts Ultra-High Fie...

2026-05-20 22:00 5837

Evolve Beyond Limits: YIZUMI CONNECT 2026 Showcases

FOSHAN, China, May 20, 2026 /PRNewswire/ -- Following its presence at CHINAPLAS 2026 in Shanghai, YIZUMI brought its latest vision for advanced molding and smart manufacturing to YIZUMI CONNECT 2026 in Nanxun, forming a twin-city platform linking the two events. YIZUMI CONNECT 2026: Full-Process...

2026-05-20 21:00 4875

Pictor and Disease Research Limited Formalise Collaboration to Advance Johne's Disease Monitoring Across New Zealand

Building on a two-year scientific collaboration and co-authored peer-reviewed publication, the collaboration supports new approaches to herd health monitoring for New Zealand's dairy and beef sectors AUCKLAND, New Zealand, May 20, 2026 /PRNewswire/ -- Pictor, a global targeted proteomics platfor...

2026-05-20 20:56 3486
1 ... 14151617181920 ... 649